JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265359

Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SYNJ2 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 3 and 68 bp deletion in exon 3. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (AB265359)
  • Sanger seq

Unknown

Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (AB265359)

Allele-2 : 68 bp deletion in exon 3.

Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (AB265359)
  • Sanger seq

Unknown

Sanger Sequencing - Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line (AB265359)

Allele-1 : 14 bp deletion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 3 and 68 bp deletion in exon 3

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265359-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265359-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265359 Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line", "number":"AB265359-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265359-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265359 Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line", "number":"AB265359-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265359-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265359-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265359 Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line", "number":"AB265359-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265359-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265359 Human SYNJ2 (Synaptojanin 2) knockout HeLa cell line", "number":"AB265359-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SYNJ2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Synaptojanin 2 also known as SYNJ2 is a protein encoded by the SYNJ2 gene. It has a molecular mass of approximately 180 kDa. Synaptojanin 2 functions as a phosphoinositide phosphatase which helps dephosphorylate phosphatidylinositol 45-bisphosphate (PIP2) to phosphatidylinositol (PI). This affects the membrane dynamics and signal transduction. The expression of synaptojanin 2 occurs in various tissues with notable abundance in the brain and testis.
Biological function summary

Synaptojanin 2 plays an important role in synaptic vesicle trafficking and endocytosis. It can function as a part of protein complexes involved in these processes. The protein is involved in rearranging the actin cytoskeleton which impacts cellular shape and movement. Its activity influences synaptic transmission efficiency by controlling the cycle of synaptic vesicles particularly in the nervous system which reflects its high expression in the brain.

Pathways

Synaptojanin 2 is closely linked to the phosphatidylinositol signaling pathway and the endocytosis pathway. These pathways are important for cellular communication and nutrient uptake. Within these pathways synaptojanin 2 interacts with proteins like dynamin a GTPase that mediates membrane fission during endocytosis. Synaptojanin 2 also functions in relation to AP-2 a clathrin adaptor complex that plays a role in vesicle formation highlighting its participation in endocytic trafficking.

Synaptojanin 2 relates to conditions such as cancer and neurodegenerative diseases. Overexpression or mutation of synaptojanin 2 associates with certain types of cancers including breast cancer potentially via disrupted signal transduction. It maintains a connection with proteins like PTEN a known tumor suppressor through its involvement in lipid signaling. In neurodegenerative diseases abnormal synaptojanin 2 function may impact neuronal health and is linked to diseases such as Alzheimer's disease. Defective phosphoinositide metabolism influences amyloid precursor protein processing implicating synaptojanin 2 in the pathology of these disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com